SCHEMBL7215539

SCHEMBL7215539

O=C(O)c1ccc(-c2nc(-c3ccc(OC(F)F)cc3)cs2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.70
RAB9A P51151 9/20 0.70
NPC1 O15118 8/20 0.70
SMN1; SMN2 Q16637 7/20 0.70
ALDH1A1 P00352 3/20 0.70
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
EIF4E P06730 1/20 0.57
MAPT P10636 3/20 0.50
POLB P06746 2/20 0.50
GAA P10253 1/20 0.50
HTT P42858 1/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
CSNK2A1 P68400 1/20 0.48
ATM Q13315 1/20 0.48
RARA P10276 1/20 0.46
RARB P10826 1/20 0.46
RARG P13631 1/20 0.46
PTPRF P10586 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12171823 0.87 EIF4E (0.60) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7220948 0.86 NPC1 (0.59) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7214925 0.82 KDM4E (0.70) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL1169786 0.81 KDM4E (0.78) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7507983 0.81 KDM4E (1.00) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7221293 0.81 KDM4E (1.00) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL14157036 0.79 KDM4E (0.80) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL14157037 0.79 KDM4E (0.80) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7215690 0.79 KDM4E (0.80) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7220939 0.79 KDM4E (0.80) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545009-B1 Imidazole, oxazole and thiazole derivatives for regulation of peroxisome proliferator-activated receptor function; improving insulin resistance, treating impaired glucose tolerance and obesity, enhancing insulin sensitivity, etc. TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-08 US disclosed